[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

EMEA (Europe, Middle East and Africa) Recombinant Factor VIII Market Report 2018

March 2018 | 102 pages | ID: E21E5A105BBEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the EMEA Recombinant Factor VIII market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Recombinant Factor VIII for these regions, from 2013 to 2025 (forecast)
  • Europe: Germany, France, UK, Russia, Italy and Benelux;
  • Middle East: Saudi Arabia, Israel, UAE and Iran;
  • Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Recombinant Factor VIII market competition by top manufacturers/players, with Recombinant Factor VIII sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Shire (Baxter)
  • Bayer
  • CSL
  • Pfizer
  • Biogen
  • Octapharma
  • NovoNordisk
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
  • 200IU
  • 250IU
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital
  • Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
EMEA (Europe, Middle East and Africa) Recombinant Factor VIII Market Report 2018

1 RECOMBINANT FACTOR VIII OVERVIEW

1.1 Product Overview and Scope of Recombinant Factor VIII
1.2 Classification of Recombinant Factor VIII
  1.2.1 EMEA Recombinant Factor VIII Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 EMEA Recombinant Factor VIII Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 200IU
  1.2.4 250IU
1.3 EMEA Recombinant Factor VIII Market by Application/End Users
  1.3.1 EMEA Recombinant Factor VIII Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Pharmacy
1.4 EMEA Recombinant Factor VIII Market by Region
  1.4.1 EMEA Recombinant Factor VIII Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 Europe Status and Prospect (2013-2025)
  1.4.3 Middle East Status and Prospect (2013-2025)
  1.4.4 Africa Status and Prospect (2013-2025)
1.5 EMEA Market Size (Value and Volume) of Recombinant Factor VIII (2013-2025)
  1.5.1 EMEA Recombinant Factor VIII Sales and Growth Rate (2013-2025)
  1.5.2 EMEA Recombinant Factor VIII Revenue and Growth Rate (2013-2025)

2 EMEA RECOMBINANT FACTOR VIII COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Recombinant Factor VIII Market Competition by Players/Manufacturers
  2.1.1 EMEA Recombinant Factor VIII Sales Volume and Market Share of Major Players (2013-2018)
  2.1.2 EMEA Recombinant Factor VIII Revenue and Share by Players (2013-2018)
  2.1.3 EMEA Recombinant Factor VIII Sale Price by Players (2013-2018)
2.2 EMEA Recombinant Factor VIII (Volume and Value) by Type/Product Category
  2.2.1 EMEA Recombinant Factor VIII Sales and Market Share by Type (2013-2018)
  2.2.2 EMEA Recombinant Factor VIII Revenue and Market Share by Type (2013-2018)
  2.2.3 EMEA Recombinant Factor VIII Sale Price by Type (2013-2018)
2.3 EMEA Recombinant Factor VIII (Volume) by Application
2.4 EMEA Recombinant Factor VIII (Volume and Value) by Region
  2.4.1 EMEA Recombinant Factor VIII Sales and Market Share by Region (2013-2018)
  2.4.2 EMEA Recombinant Factor VIII Revenue and Market Share by Region (2013-2018)
  2.4.3 EMEA Recombinant Factor VIII Sales Price by Region (2013-2018)

3 EUROPE RECOMBINANT FACTOR VIII (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Recombinant Factor VIII Sales and Value (2013-2018)
  3.1.1 Europe Recombinant Factor VIII Sales Volume and Growth Rate (2013-2018)
  3.1.2 Europe Recombinant Factor VIII Revenue and Growth Rate (2013-2018)
3.2 Europe Recombinant Factor VIII Sales and Market Share by Type
3.3 Europe Recombinant Factor VIII Sales and Market Share by Application
3.4 Europe Recombinant Factor VIII Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Recombinant Factor VIII Sales Volume by Countries (2013-2018)
  3.4.2 Europe Recombinant Factor VIII Revenue by Countries (2013-2018)
  3.4.3 Germany Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  3.4.4 France Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  3.4.5 UK Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  3.4.6 Russia Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  3.4.7 Italy Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  3.4.8 Benelux Recombinant Factor VIII Sales and Growth Rate (2013-2018)

4 MIDDLE EAST RECOMBINANT FACTOR VIII (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Recombinant Factor VIII Sales and Value (2013-2018)
  4.1.1 Middle East Recombinant Factor VIII Sales Volume and Growth Rate (2013-2018)
  4.1.2 Middle East Recombinant Factor VIII Revenue and Growth Rate (2013-2018)
4.2 Middle East Recombinant Factor VIII Sales and Market Share by Type
4.3 Middle East Recombinant Factor VIII Sales and Market Share by Application
4.4 Middle East Recombinant Factor VIII Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Recombinant Factor VIII Sales Volume by Countries (2013-2018)
  4.4.2 Middle East Recombinant Factor VIII Revenue by Countries (2013-2018)
  4.4.3 Saudi Arabia Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  4.4.4 Israel Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  4.4.5 UAE Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  4.4.6 Iran Recombinant Factor VIII Sales and Growth Rate (2013-2018)

5 AFRICA RECOMBINANT FACTOR VIII (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Recombinant Factor VIII Sales and Value (2013-2018)
  5.1.1 Africa Recombinant Factor VIII Sales Volume and Growth Rate (2013-2018)
  5.1.2 Africa Recombinant Factor VIII Revenue and Growth Rate (2013-2018)
5.2 Africa Recombinant Factor VIII Sales and Market Share by Type
5.3 Africa Recombinant Factor VIII Sales and Market Share by Application
5.4 Africa Recombinant Factor VIII Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Recombinant Factor VIII Sales Volume by Countries (2013-2018)
  5.4.2 Africa Recombinant Factor VIII Revenue by Countries (2013-2018)
  5.4.3 South Africa Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  5.4.4 Nigeria Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  5.4.5 Egypt Recombinant Factor VIII Sales and Growth Rate (2013-2018)
  5.4.6 Algeria Recombinant Factor VIII Sales and Growth Rate (2013-2018)

6 EMEA RECOMBINANT FACTOR VIII MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Shire (Baxter)
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Factor VIII Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Shire (Baxter) Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Bayer
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Factor VIII Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 CSL
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Factor VIII Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 CSL Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Factor VIII Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Biogen
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Factor VIII Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Biogen Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Octapharma
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Recombinant Factor VIII Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Octapharma Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 NovoNordisk
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Recombinant Factor VIII Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 NovoNordisk Recombinant Factor VIII Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 RECOMBINANT FACTOR VIII MANUFACTURING COST ANALYSIS

7.1 Recombinant Factor VIII Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Factor VIII

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Factor VIII Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Factor VIII Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RECOMBINANT FACTOR VIII MARKET FORECAST (2018-2025)

11.1 EMEA Recombinant Factor VIII Sales, Revenue and Price Forecast (2018-2025)
  11.1.1 EMEA Recombinant Factor VIII Sales and Growth Rate Forecast (2018-2025)
  11.1.2 EMEA Recombinant Factor VIII Revenue and Growth Rate Forecast (2018-2025)
  11.1.3 EMEA Recombinant Factor VIII Price and Trend Forecast (2018-2025)
11.2 EMEA Recombinant Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.3 Europe Recombinant Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.4 Middle Eastt Recombinant Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.5 Africa Recombinant Factor VIII Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
11.6 EMEA Recombinant Factor VIII Sales Forecast by Type (2018-2025)
11.7 EMEA Recombinant Factor VIII Sales Forecast by Application (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Factor VIII
Figure EMEA Recombinant Factor VIII Sales Volume (K Units) by Type (2013-2025)
Figure EMEA Recombinant Factor VIII Sales Volume Market Share by Type (Product Category) in 2017
Figure 200IU Product Picture
Figure 250IU Product Picture
Figure EMEA Recombinant Factor VIII Sales Volume (K Units) by Application (2013-2025)
Figure EMEA Sales Market Share of Recombinant Factor VIII by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmacy Examples
Table Key Downstream Customer in Pharmacy
Figure EMEA Recombinant Factor VIII Market Size (Million USD) by Region (2013-2025)
Figure Europe Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Recombinant Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Middle East Recombinant Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure Africa Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure Africa Recombinant Factor VIII Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Recombinant Factor VIII Sales Volume and Growth Rate (2013-2025)
Figure EMEA Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2025)
Figure EMEA Recombinant Factor VIII Market Major Players Product Sales Volume (K Units) (2013-2018)
Table EMEA Recombinant Factor VIII Sales Volume (K Units) of Major Players (2013-2018)
Table EMEA Recombinant Factor VIII Sales Share by Players (2013-2018)
Figure 2017 Recombinant Factor VIII Sales Share by Players
Figure 2017 Recombinant Factor VIII Sales Share by Players
Figure EMEA Recombinant Factor VIII Market Major Players Product Revenue (Million USD) (2013-2018)
Table EMEA Recombinant Factor VIII Revenue (Million USD) by Players (2013-2018)
Table EMEA Recombinant Factor VIII Revenue Share by Players (2013-2018)
Table 2017 EMEA Recombinant Factor VIII Revenue Share by Players
Table 2017 EMEA Recombinant Factor VIII Revenue Share by Players
Table EMEA Recombinant Factor VIII Sale Price (USD/Unit) by Players (2013-2018)
Table EMEA Recombinant Factor VIII Sales (K Units) and Market Share by Type (2013-2018)
Table EMEA Recombinant Factor VIII Sales Share by Type (2013-2018)
Figure Sales Market Share of Recombinant Factor VIII by Type (2013-2018)
Figure EMEA Recombinant Factor VIII Sales Market Share by Type (2013-2018)
Table EMEA Recombinant Factor VIII Revenue (Million USD) and Market Share by Type (2013-2018)
Table EMEA Recombinant Factor VIII Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Recombinant Factor VIII by Type in 2017
Table EMEA Recombinant Factor VIII Sale Price (USD/Unit) by Type (2013-2018)
Table EMEA Recombinant Factor VIII Sales (K Units) and Market Share by Application (2013-2018)
Table EMEA Recombinant Factor VIII Sales Share by Application (2013-2018)
Figure Sales Market Share of Recombinant Factor VIII by Application (2013-2018)
Figure EMEA Recombinant Factor VIII Sales Market Share by Application in 2017
Table EMEA Recombinant Factor VIII Sales (K Units) and Market Share by Region (2013-2018)
Table EMEA Recombinant Factor VIII Sales Share by Region (2013-2018)
Figure Sales Market Share of Recombinant Factor VIII by Region (2013-2018)
Figure EMEA Recombinant Factor VIII Sales Market Share in 2017
Table EMEA Recombinant Factor VIII Revenue (Million USD) and Market Share by Region (2013-2018)
Table EMEA Recombinant Factor VIII Revenue Share by Region (2013-2018)
Figure Revenue Market Share of Recombinant Factor VIII by Region (2013-2018)
Figure EMEA Recombinant Factor VIII Revenue Market Share Regions in 2017
Table EMEA Recombinant Factor VIII Sales Price (USD/Unit) by Region (2013-2018)
Figure Europe Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Europe Recombinant Factor VIII Revenue and Growth Rate (2013-2018)
Table Europe Recombinant Factor VIII Sales (K Units) by Type (2013-2018)
Table Europe Recombinant Factor VIII Market Share by Type (2013-2018)
Figure Europe Recombinant Factor VIII Market Share by Type in 2017
Table Europe Recombinant Factor VIII Sales (K Units) by Application (2013-2018)
Table Europe Recombinant Factor VIII Market Share by Application (2013-2018)
Figure Europe Recombinant Factor VIII Market Share by Application in 2017
Table Europe Recombinant Factor VIII Sales (K Units) by Countries (2013-2018)
Table Europe Recombinant Factor VIII Sales Market Share by Countries (2013-2018)
Figure Europe Recombinant Factor VIII Sales Market Share by Countries (2013-2018)
Figure Europe Recombinant Factor VIII Sales Market Share by Countries in 2017
Table Europe Recombinant Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Europe Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Europe Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Europe Recombinant Factor VIII Revenue Market Share by Countries in 2017
Figure Germany Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure France Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure UK Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Russia Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Italy Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Benelux Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Middle East Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2018)
Table Middle East Recombinant Factor VIII Sales (K Units) by Type (2013-2018)
Table Middle East Recombinant Factor VIII Market Share by Type (2013-2018)
Figure Middle East Recombinant Factor VIII Market Share by Type (2013-2018)
Table Middle East Recombinant Factor VIII Sales (K Units) by Applications (2013-2018)
Table Middle East Recombinant Factor VIII Market Share by Applications (2013-2018)
Figure Middle East Recombinant Factor VIII Sales Market Share by Application in 2017
Table Middle East Recombinant Factor VIII Sales Volume (K Units) by Countries (2013-2018)
Table Middle East Recombinant Factor VIII Sales Volume Market Share by Countries (2013-2018)
Figure Middle East Recombinant Factor VIII Sales Volume Market Share by Countries in 2017
Table Middle East Recombinant Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Middle East Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Middle East Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Middle East Recombinant Factor VIII Revenue Market Share by Countries in 2017
Figure Saudi Arabia Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Israel Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure UAE Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Iran Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Africa Recombinant Factor VIII Revenue (Million USD) and Growth Rate (2013-2018)
Table Africa Recombinant Factor VIII Sales (K Units) by Type (2013-2018)
Table Africa Recombinant Factor VIII Sales Market Share by Type (2013-2018)
Figure Africa Recombinant Factor VIII Sales Market Share by Type (2013-2018)
Figure Africa Recombinant Factor VIII Sales Market Share by Type in 2017
Table Africa Recombinant Factor VIII Sales (K Units) by Application (2013-2018)
Table Africa Recombinant Factor VIII Sales Market Share by Application (2013-2018)
Figure Africa Recombinant Factor VIII Sales Market Share by Application (2013-2018)
Table Africa Recombinant Factor VIII Sales Volume (K Units) by Countries (2013-2018)
Table Africa Recombinant Factor VIII Sales Market Share by Countries (2013-2018)
Figure Africa Recombinant Factor VIII Sales Market Share by Countries (2013-2018)
Figure Africa Recombinant Factor VIII Sales Market Share by Countries in 2017
Table Africa Recombinant Factor VIII Revenue (Million USD) by Countries (2013-2018)
Table Africa Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Africa Recombinant Factor VIII Revenue Market Share by Countries (2013-2018)
Figure Africa Recombinant Factor VIII Revenue Market Share by Countries in 2017
Figure South Africa Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Nigeria Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Egypt Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Algeria Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Table Shire (Baxter) Recombinant Factor VIII Basic Information List
Table Shire (Baxter) Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire (Baxter) Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Shire (Baxter) Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Shire (Baxter) Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Bayer Recombinant Factor VIII Basic Information List
Table Bayer Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Bayer Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table CSL Recombinant Factor VIII Basic Information List
Table CSL Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure CSL Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure CSL Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure CSL Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Pfizer Recombinant Factor VIII Basic Information List
Table Pfizer Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Pfizer Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Pfizer Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Biogen Recombinant Factor VIII Basic Information List
Table Biogen Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Biogen Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Biogen Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Biogen Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Octapharma Recombinant Factor VIII Basic Information List
Table Octapharma Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Octapharma Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure Octapharma Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure Octapharma Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table NovoNordisk Recombinant Factor VIII Basic Information List
Table NovoNordisk Recombinant Factor VIII Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure NovoNordisk Recombinant Factor VIII Sales (K Units) and Growth Rate (2013-2018)
Figure NovoNordisk Recombinant Factor VIII Sales Market Share in EMEA (2013-2018)
Figure NovoNordisk Recombinant Factor VIII Revenue Market Share in EMEA (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Factor VIII
Figure Manufacturing Process Analysis of Recombinant Factor VIII
Figure Recombinant Factor VIII Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Factor VIII Major Manufacturers in 2017
Table Major Buyers of Recombinant Factor VIII
Table Distributors/Traders List
Figure EMEA Recombinant Factor VIII Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure EMEA Recombinant Factor VIII Revenue and Growth Rate Forecast (2018-2025)
Figure EMEA Recombinant Factor VIII Price (USD/Unit) and Trend Forecast (2018-2025)
Table EMEA Recombinant Factor VIII Sales (K Units) Forecast by Region (2018-2025)
Figure EMEA Recombinant Factor VIII Sales Market Share Forecast by Region (2018-2025)
Table EMEA Recombinant Factor VIII Revenue (Million USD) Forecast by Region (2018-2025)
Figure EMEA Recombinant Factor VIII Revenue Market Share Forecast by Region (2018-2025)
Table Europe Recombinant Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Europe Recombinant Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Europe Recombinant Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Europe Recombinant Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table Middle East Recombinant Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Middle East Recombinant Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Middle East Recombinant Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Middle East Recombinant Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table Africa Recombinant Factor VIII Sales (K Units) Forecast by Countries (2018-2025)
Figure Africa Recombinant Factor VIII Sales Market Share Forecast by Countries (2018-2025)
Table Africa Recombinant Factor VIII Revenue (Million USD) Forecast by Countries (2018-2025)
Figure Africa Recombinant Factor VIII Revenue Market Share Forecast by Countries (2018-2025)
Table EMEA Recombinant Factor VIII Sales (K Units) Forecast by Type (2018-2025)
Figure EMEA Recombinant Factor VIII Sales Market Share Forecast by Type (2018-2025)
Table EMEA Recombinant Factor VIII Sales (K Units) Forecast by Application (2018-2025)
Figure EMEA Recombinant Factor VIII Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories